Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Prevention of GBS Colonization Via Immunity: Complete Statistical AnalysisIndependent statistical analysis of Prevention of GBS Colonization Via Immunity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00128219).
- Prevention of Musculoskeletal Injuries in Slovenian Armed Forces: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Musculoskeletal Injuries in Slovenian Armed Forces: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03415464).
- Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): Complete Statistical AnalysisIndependent statistical analysis of Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00602420).
- Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients: Complete Statistical AnalysisIndependent statistical analysis of Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00381615).
- Preventive Care of Chronic Cervical Pain and Disabilities: Complete Statistical AnalysisIndependent statistical analysis of Preventive Care of Chronic Cervical Pain and Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00566930).
- PRIDEIndependent statistical analysis of A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRIDEIndependent statistical analysis of Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE):…
- PRIDEC PeruIndependent statistical analysis of Safety of Lactobacillus Reuteri in Healthy Children Aged 2-24 Months: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02460575).
- PRidopidine’s Outcome On Function in Huntington Disease, PROOF- HD: Complete Statistical AnalysisIndependent statistical analysis of PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04556656).
- PRIISMIndependent statistical analysis of Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice: Complete Statistical AnalysisIndependent statistical analysis of PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size…
- Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.: Complete Statistical AnalysisIndependent statistical analysis of Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.: primary endpoint results,…
- Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00203502).
- Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™: Complete Statistical AnalysisIndependent statistical analysis of Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™: Complete Statistical AnalysisIndependent statistical analysis of Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PRIMCABIndependent statistical analysis of Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide: primary endpoint results,…
- PRIMEIndependent statistical analysis of Pain Reduction With Intranasal Medications for Extremity Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02778880).
- PRIMEIndependent statistical analysis of Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PRIME CareIndependent statistical analysis of PRIME Care (PRecision Medicine In MEntal Health Care): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03170362).
- PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy: Complete Statistical AnalysisIndependent statistical analysis of PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Primed vs. Unprimed rTMS in Chronic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Primed vs. Unprimed rTMS in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01757821).
- Priming Expectations and Motor Learning With tDCS: Complete Statistical AnalysisIndependent statistical analysis of Priming Expectations and Motor Learning With tDCS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06039605).
- PRINCEIndependent statistical analysis of PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions: Complete Statistical AnalysisIndependent statistical analysis of Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00557947).
- Prineo Sensitivity Dressing Study: Complete Statistical AnalysisIndependent statistical analysis of Prineo Sensitivity Dressing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06011603).
- PRINTOJDMTRIndependent statistical analysis of Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00323960).
- PRIORAIndependent statistical analysis of A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- PRISMIndependent statistical analysis of Efficacy and Safety Study of I10E in Treatment of Patients With CIDP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRiSMIndependent statistical analysis of Patient Response to Spinal Manipulation - Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01562756).
- PRISM-ACIndependent statistical analysis of The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PRKIndependent statistical analysis of Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high Astigmatism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRNIndependent statistical analysis of Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRO 140 in Treatment-Experienced HIV-1 Subjects: Complete Statistical AnalysisIndependent statistical analysis of PRO 140 in Treatment-Experienced HIV-1 Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03902522).
- PRO SoloIndependent statistical analysis of Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03478969).
- PRO-087/IIndependent statistical analysis of Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRO-DEFENSEIndependent statistical analysis of Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRO-HFIndependent statistical analysis of Patient-Reported Outcome Measurement in Heart Failure Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04164004).
- PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg: Complete Statistical AnalysisIndependent statistical analysis of PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PRO-SCALPIndependent statistical analysis of A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of…
- ProACTIndependent statistical analysis of ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROACTIVEIndependent statistical analysis of PRV-015 in Gluten-free Diet Non-responsive Celiac Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04424927).
- Probability Ramp Control of Propofol for EGD: Complete Statistical AnalysisIndependent statistical analysis of Probability Ramp Control of Propofol for EGD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01838304).
- Probing Cortical Excitability and Cognitive Function With TMS: Complete Statistical AnalysisIndependent statistical analysis of Probing Cortical Excitability and Cognitive Function With TMS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03652012).
- PROBIOLACIndependent statistical analysis of Global Effects of a Probiotic Strain on Lactating Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124448).
- Probiotics as Adjuvant Treatment for Bacterial Vaginosis: Complete Statistical AnalysisIndependent statistical analysis of Probiotics as Adjuvant Treatment for Bacterial Vaginosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03894813).
- Problem-Solving Skills Training to Improve Care for Children With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Problem-Solving Skills Training to Improve Care for Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00250588).
- ProBPIndependent statistical analysis of Clinical Trial of Dietary Protein and Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00046566).
- ProBPIndependent statistical analysis of Clinical Trial of Protein and Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107744).
- Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: Complete Statistical AnalysisIndependent statistical analysis of Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…